Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Evonik establishes new enzymatic process for serine

17.10.2013
• Evonik Industries has developed a new process for the enzymatic synthesis of the amino acid D-serine, L-serine und DL-serine
• Production capacities at the Nanning site (China) have been increased
• Full backward integration offers customers the highest level of supply security and product quality

Evonik Industries has developed a new, more efficient process for the enzymatic synthesis of the amino acid serine—it is, among other things, required for the production of pharmaceutical ingredients.

To implement the new enzymatic synthesis on a large scale, the Group has expanded the existing production plants at its Nanning site in China. This new process allows Evonik to manufacture serine in all enantiomeric forms: L-serine, D-serine, and DL-serine.

“With the expansion of the production capacities in Nanning we can produce serine in all forms while being fully backward integrated,” says Dr. Jean-Luc Herbeaux, Head of the Health Care Business Line of Evonik. “

“By controlling the entire supply chain, we areclearly a highly reliable partner for our customers—both with regard to supply security and product quality.”

Dr. Thomas Hermann, Vice President of the Rexim Product Line adds: “Because of our technological expertise, we are able to offer all serine-derivatives currently on the market. This gives Evonik a unique value proposition in the market.”

L-serine is one of the non-essential amino acids that are naturally occuring in the human body. It plays an important role in protein synthesis. The main areas of application of L-serine are nutrition and pharmaceutics, but it is also used in the cosmetics industry. In the area of nutrition, amino acids are, for example, used in hypoallergenic follow-on milk for newborns with lactose intolerance, or sports nutrition. L-serine is used in pharmaceutics as a building block for pharmaceutical ingredients or in parenteral nutrition. In the cosmetics sector it is mainly used in skin and hair care products. D-serine and DL-serine are used for the synthesis of various pharmaceutical ingredients.

Evonik offers serine in all quality grades: from technical quality for chiral synthesis to GMP-quality for pharmaceutical applications.

Company information
Evonik, the creative industrial group from Germany, is one of the world leaders

in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).

Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Dr. Jürgen Krauter | idw
Further information:
http://www.evonik.com

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>